ArticleInvestigational new drugs2022

Phase 1 study to evaluate the effects of rifampin on pharmacokinetics of pevonedistat, a NEDD8-activating enzyme inhibitor in patients with advanced solid tumors.

Xiaofei Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.